Paul H.A. Quax

16.0k total citations
295 papers, 11.7k citations indexed

About

Paul H.A. Quax is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Paul H.A. Quax has authored 295 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 98 papers in Cancer Research and 86 papers in Immunology. Recurrent topics in Paul H.A. Quax's work include Protease and Inhibitor Mechanisms (60 papers), Angiogenesis and VEGF in Cancer (60 papers) and Atherosclerosis and Cardiovascular Diseases (54 papers). Paul H.A. Quax is often cited by papers focused on Protease and Inhibitor Mechanisms (60 papers), Angiogenesis and VEGF in Cancer (60 papers) and Atherosclerosis and Cardiovascular Diseases (54 papers). Paul H.A. Quax collaborates with scholars based in Netherlands, United States and Germany. Paul H.A. Quax's co-authors include Margreet R. de Vries, J. Wouter Jukema, Victor W.M. van Hinsbergh, Jan H. Verheijen, Jos Grimbergen, A. Yaël Nossent, Gerard Pasterkamp, Marten A. Engelse, J. Hajo van Bockel and Imo E. Hoefer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Paul H.A. Quax

292 papers receiving 11.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul H.A. Quax Netherlands	59	5.2k	3.0k	2.6k	2.4k	1.6k	295	11.7k
Victor W.M. van Hinsbergh Netherlands	71	5.6k 1.1×	2.7k 0.9×	2.3k 0.9×	2.4k 1.0×	1.4k 0.9×	260	16.2k
Florea Lupu United States	60	4.3k 0.8×	2.7k 0.9×	3.4k 1.3×	1.7k 0.7×	1.2k 0.7×	182	12.3k
Esther Lutgens Netherlands	56	4.0k 0.8×	2.2k 0.7×	5.4k 2.1×	1.4k 0.6×	1.4k 0.9×	201	11.6k
Liliana Schaefer Germany	64	6.5k 1.2×	2.1k 0.7×	2.8k 1.1×	1.2k 0.5×	1.3k 0.8×	193	14.0k
Hellmut G. Augustin Germany	79	11.0k 2.1×	3.4k 1.1×	2.7k 1.0×	1.9k 0.8×	4.3k 2.6×	206	19.0k
Renate E. Gay Switzerland	65	5.5k 1.0×	2.6k 0.9×	3.5k 1.4×	850 0.4×	2.1k 1.3×	174	13.4k
Katherine A. Hajjar United States	55	5.7k 1.1×	3.8k 1.3×	1.9k 0.7×	1.5k 0.6×	1.7k 1.1×	116	12.0k
Dominique P.V. de Kleijn Netherlands	60	6.4k 1.2×	3.1k 1.0×	2.9k 1.1×	3.1k 1.3×	812 0.5×	266	14.5k
Jennifer R. Gamble Australia	64	6.0k 1.1×	1.5k 0.5×	4.8k 1.8×	1.7k 0.7×	1.3k 0.8×	157	14.4k
Anton Jan van Zonneveld Netherlands	57	5.0k 0.9×	3.1k 1.0×	1.1k 0.4×	1.3k 0.5×	874 0.5×	211	10.6k

Countries citing papers authored by Paul H.A. Quax

Since Specialization

Citations

This map shows the geographic impact of Paul H.A. Quax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H.A. Quax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H.A. Quax more than expected).

Fields of papers citing papers by Paul H.A. Quax

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H.A. Quax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H.A. Quax. The network helps show where Paul H.A. Quax may publish in the future.

Co-authorship network of co-authors of Paul H.A. Quax

This figure shows the co-authorship network connecting the top 25 collaborators of Paul H.A. Quax. A scholar is included among the top collaborators of Paul H.A. Quax based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H.A. Quax. Paul H.A. Quax is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bent, M. Leontien van der, Thuy Nguyen, Marieke J.H. Wermer, et al.. (2025). Validation of tRNA-derived fragments as diagnostic biomarkers in suspected acute stroke; limitations in analysis and quantification methods. Molecular Therapy — Nucleic Acids. 36(2). 102553–102553. 1 indexed citations

Quax, Paul H.A., et al.. (2022). N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4. International Journal of Molecular Sciences. 23(3). 1057–1057. 28 indexed citations

Dijk, Elon H. C. van, Szymon M. Kiełbasa, Hailiang Mei, et al.. (2021). The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy. The Journal of Clinical Endocrinology & Metabolism. 107(2). 512–524. 15 indexed citations

Parma, Laura, et al.. (2020). bFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice. Scientific Reports. 10(1). 15968–15968. 25 indexed citations

Quax, Paul H.A., M. Carini, Joan Albert Barberà, et al.. (2019). Metabolic Alterations in Cardiopulmonary Vascular Dysfunction. Frontiers in Molecular Biosciences. 5. 120–120. 23 indexed citations

Lijkwan, M.A., Koen E.A. van der Bogt, Mei Huang, et al.. (2013). Short Hairpin RNA Gene Silencing of Prolyl Hydroxylase-2 with a Minicircle Vector Improves Neovascularization of Hindlimb Ischemia. Human Gene Therapy. 25(1). 41–49. 28 indexed citations

Karper, Jacco C., Saskia C.A. de Jager, M.M. Ewing, et al.. (2011). Abstract 14685: RP105, A Cell Surface TLR4 Signaling Regulator, Enhances Atherosclerotic Plaque Formation. Circulation. 124. 253–4. 1 indexed citations

Pettersson, Knut, M.M. Ewing, Margreet R. de Vries, et al.. (2011). Abstract 15644: A Fully Human Monoclonal IgG Phosphorylcholine Antibody Prevents Accelerated Atherosclerosis in Mice. Circulation. 124. 2 indexed citations

Nossent, A. Yaël, et al.. (2011). SNPs in MicroRNA Binding Sites in 3′-UTRs of RAAS Genes Influence Arterial Blood Pressure and Risk of Myocardial Infarction. American Journal of Hypertension. 24(9). 999–1006. 75 indexed citations

10.

Vlugt, Luciën E. P. M. van der, M.A. Lijkwan, A.J.N.M. Bastiaansen, et al.. (2011). A limited role for regulatory T cells in post‐ischemic neovascularization. Journal of Cellular and Molecular Medicine. 16(2). 328–336. 19 indexed citations

11.

Wierda, Rutger J., Hedwich F. Kuipers, Marja C.J.A. van Eggermond, et al.. (2011). Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors. Journal of Cellular and Molecular Medicine. 16(8). 1866–1877. 22 indexed citations

12.

Ewing, M.M., Jeffrey J. W. Verschuren, M. Lourdes Sampietro, et al.. (2010). Annexin A5: genotypic risk marker for clinical restenosis after percutaneous coronary intervention. European Heart Journal. 31. 803–803. 1 indexed citations

13.

Stone, Oliver A., Christine Richer, Costanza Emanueli, et al.. (2009). Critical Role of Tissue Kallikrein in Vessel Formation and Maturation. Arteriosclerosis Thrombosis and Vascular Biology. 29(5). 657–664. 48 indexed citations

14.

Eefting, D., Margreet R. de Vries, Jos Grimbergen, et al.. (2009). In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor. Journal of Vascular Surgery. 51(2). 429–437. 15 indexed citations

15.

Pons, Douwe, F. R. de Vries, Peter J. van den Elsen, et al.. (2008). Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. European Heart Journal. 30(3). 266–277. 138 indexed citations

16.

Schepers, Abbey, Nuno Pires, D. Eefting, et al.. (2006). Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice. Journal of Vascular Surgery. 43(4). 809–815. 24 indexed citations

17.

Krom, Yvonne D., Nuno Pires, J. Wouter Jukema, et al.. (2006). Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists. Cardiovascular Research. 73(1). 217–226. 18 indexed citations

18.

Pires, Nuno, J. Wouter Jukema, Mat J.A.P. Daemen, & Paul H.A. Quax. (2006). Drug-eluting stents studies in mice: Do we need atherosclerosis to study restenosis?. Vascular Pharmacology. 44(5). 257–264. 8 indexed citations

19.

Quax, Paul H.A., et al.. (1992). The Plasminogen Activator System in Extracellular Matrix Degradation. Research at the University of Copenhagen (University of Copenhagen). 10 indexed citations

20.

Quax, Paul H.A., Nina Marie Pedersen, Maria Teresa Masucci, et al.. (1991). Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation.. PubMed. 2(10). 793–803. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact